机构:
Zhejiang Univ, Affiliated Hosp 1, Sch Med, Ctr Canc, Hangzhou 310003, Peoples R ChinaZhejiang Univ, Affiliated Hosp 1, Sch Med, Ctr Canc, Hangzhou 310003, Peoples R China
Teng, Li-Song
[1
]
Zheng, Yi
论文数: 0引用数: 0
h-index: 0
机构:
Zhejiang Univ, Affiliated Hosp 1, Sch Med, Ctr Canc, Hangzhou 310003, Peoples R ChinaZhejiang Univ, Affiliated Hosp 1, Sch Med, Ctr Canc, Hangzhou 310003, Peoples R China
Zheng, Yi
[1
]
Wang, Hao-Hao
论文数: 0引用数: 0
h-index: 0
机构:
Zhejiang Univ, Affiliated Hosp 1, Sch Med, Ctr Canc, Hangzhou 310003, Peoples R ChinaZhejiang Univ, Affiliated Hosp 1, Sch Med, Ctr Canc, Hangzhou 310003, Peoples R China
Wang, Hao-Hao
[1
]
机构:
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Ctr Canc, Hangzhou 310003, Peoples R China
来源:
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B
|
2008年
/
9卷
/
02期
基金:
中国国家自然科学基金;
关键词:
BRCA1;
BRCA2;
hereditary breast cancer;
D O I:
10.1631/jzus.B0710617
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Breast cancer is one of the leading causes of death in women today. Some of the patients are hereditary, with a large proportion characterized by mutation in BRCA1 and/or BRCA2 genes. In this review, we provide an overview of these two genes, focusing on their relationship with hereditary breast cancers. BRCA1/2 associated hereditary breast cancers have unique features that differ from the general breast cancers, including alterations in cellular molecules, pathological bases, biological behavior, and a different prevention strategy. But the outcome of BRCA1/2 associated hereditary breast cancers still remains controversial; further studies are needed to elucidate the nature of BRCA1/2 associated hereditary breast cancers.
机构:Portuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Fragoso, S.
Santos, S.
论文数: 0引用数: 0
h-index: 0
机构:Portuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Santos, S.
Mira, B.
论文数: 0引用数: 0
h-index: 0
机构:
Portuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, PortugalPortuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Mira, B.
Machado, P.
论文数: 0引用数: 0
h-index: 0
机构:Portuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Machado, P.
Luis, A.
论文数: 0引用数: 0
h-index: 0
机构:
Portuguese Inst Oncol Francisco Gentil, Breast Ovarian Canc Risk Evaluat Clin, Lisbon, PortugalPortuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Luis, A.
Clara, A.
论文数: 0引用数: 0
h-index: 0
机构:
Portuguese Inst Oncol Francisco Gentil, Breast Ovarian Canc Risk Evaluat Clin, Lisbon, PortugalPortuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Clara, A.
Opiniao, A.
论文数: 0引用数: 0
h-index: 0
机构:
Portuguese Inst Oncol Francisco Gentil, Breast Ovarian Canc Risk Evaluat Clin, Lisbon, PortugalPortuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Opiniao, A.
Bento, S.
论文数: 0引用数: 0
h-index: 0
机构:
Portuguese Inst Oncol Francisco Gentil, Breast Ovarian Canc Risk Evaluat Clin, Lisbon, PortugalPortuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Bento, S.
Miguel, I.
论文数: 0引用数: 0
h-index: 0
机构:
Portuguese Inst Oncol Francisco Gentil, Breast Ovarian Canc Risk Evaluat Clin, Lisbon, PortugalPortuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Miguel, I.
Rodrigues, P.
论文数: 0引用数: 0
h-index: 0
机构:
Portuguese Inst Oncol Francisco Gentil, Breast Ovarian Canc Risk Evaluat Clin, Lisbon, PortugalPortuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Rodrigues, P.
Parreira, J.
论文数: 0引用数: 0
h-index: 0
机构:
Portuguese Inst Oncol Francisco Gentil, Breast Ovarian Canc Risk Evaluat Clin, Lisbon, PortugalPortuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Parreira, J.
Simoes, C.
论文数: 0引用数: 0
h-index: 0
机构:
Portuguese Inst Oncol Francisco Gentil, Breast Ovarian Canc Risk Evaluat Clin, Lisbon, PortugalPortuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal
Simoes, C.
Vaz, F.
论文数: 0引用数: 0
h-index: 0
机构:
Portuguese Inst Oncol Francisco Gentil, Breast Ovarian Canc Risk Evaluat Clin, Lisbon, PortugalPortuguese Inst Oncol Francisco Gentil, Med Oncol Dept, Lisbon, Portugal